亚太地区免疫组织化学市场预测至 2028 年 - 按应用(诊断和药物检测)、产品(抗体、设备、试剂和试剂盒)和最终用户(医院和诊断实验室、研究机构等)划分的 COVID-19 影响和区域分析)

TIPRE00025746 | Pages: 150 | Biotechnology | Nov 2021 | Type: Regional | Status: Published

市场介绍

亚太地区是免疫组化增长最快的区域市场;中国、印度、日本、韩国、澳大利亚和亚太地区其他国家是该地区市场的主要贡献者。中国在 2021 年引领市场。该市场的增长归因于研发活动的增加、发展中国家医疗保健行业投资的增加以及监管外包与药物开发商之间的合作增加。市场参与者正在推出产品。例如,2020 年 8 月,吉利德科学公司 (Gilead Sciences Inc.) 的 Truvada 获得批准,这是一种艾滋病毒预防药物,可在中国用于成人和青少年药物。这一批准将有助于在健康人群中预防艾滋病毒。许多传染病正在亚洲和太平洋地区新出现、重新出现或导致反复爆发。人们出行更加频繁、居住在人口更加密集的地区以及与野生动物的接触更加密切,增加了新发传染病迅速传播的可能性。当前的COVID-19情况还增加了对人群中流感病毒的监测,以提高对该疾病的诊断。据中国国家卫生健康委员会(NHC)统计,截至2020年3月26日,中国累计报告新冠病毒感染病例81,285例,累计死亡3,287例。该疾病在最初阶段传播速度很快。然而,轮状病毒、AE 型肝炎病毒、登革热病毒等不同病毒感染引起的疾病的流行预计也会在预测期内推动市场。传染病复发率的上升、诊断能力的提高以及有关更好地了解病毒性疾病的政府计划的增加预计将推动未来几年免疫组织化学市场的增长。

亚太地区国家,尤其是印度,由于 COVID-19 爆发,受到严重影响。供应链的混乱以及对有效治疗 COVID-19 的巨大需求使亚太地区的医疗保健研究行业处于至关重要的境地。已采取禁止措施来控制新型冠状病毒的传播。 COVID-19 大流行对该地区的经济产生了不利影响。社会经济受到严重影响,负通胀率上升,GDP负增长,地区失业率激增。中国、日本、新加坡和韩国等国家对临床试验的兴趣日益浓厚。西方国家的高成本也促使医疗事务外包流向亚太地区。为了扩大亚洲市场的销售,制药公司开始意识到药物、设备和体外诊断的新的和不断变化的监管环境。亚洲经常实施新的或改进的法规,包括 GMP 标准、药品价格控制和医疗器械监管体系的变化。作为当前标准的任何收购或任何改进的一部分,都需要第三方指导和建议。第三方外包服务提供商在支持亚太地区相关市场方面日益发挥着重要作用。然而,由于相关市场的控制程序、人们的意识、疫苗接种情况以及政府对企业的支持政策,与大流行初期相比,市场已趋于稳定。

< u>市场概况与动态

亚太地区免疫组织化学市场预计将从2021年的4.8376亿美元增长到2028年的8.1800亿美元;预计 2021 年至 2028 年复合年增长率为 7.8%。 免疫组织化学 (IHC) 是指单克隆和多克隆抗体用于特定疾病抗原的组织测定和分布的重要应用。它主要用于检测登革热、肝炎、人类免疫缺陷病毒(HIV)等多种传染病。肥胖、癌症、糖尿病、心脏病和中风等慢性疾病也被认为是免疫组织化学的主要应用,有助于诊断这些疾病。糖尿病在该地区的老年人口中发病率很高。超重和肥胖人群中糖尿病的患病率更高。该地区发达经济体和发展中经济体的肥胖率都在迅速上升。不健康的生活方式和久坐的生活等因素是肥胖人数增加的主要原因。心血管疾病(CVD)包括脑血管疾病、风湿性心脏病、冠心病和其他病症。它是整个地区发病率和死亡率的最重要原因。此外,该地区癌症发病率和死亡率不断上升,使癌症成为主要死亡原因。慢性病和传染病发病率的增加预计将在亚太地区产生对免疫测定测试的需求。

主要细分市场

从产品来看,抗体细分市场在2020年亚太地区免疫组化市场中占据最大份额。从应用来看,诊断细分市场在2020年亚太地区免疫组化市场中占据了更大的市场份额。此外, 2020 年,按最终用户计算,医院和诊断实验室细分市场在亚太地区免疫组织化学市场中占有较大份额。

主要来源和上市公司

准备本亚太地区免疫组织化学市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有 Abcam plc;安捷伦科技公司;生物SB;生物拉德实验室有限公司;细胞信号技术公司;丹纳赫; F. 霍夫曼拉罗什有限公司;默克公司;珀金埃尔默公司;和 THERMO FISHER SCIENTIFIC INC

购买报告的理由

  • 了解亚太地区免疫组织化学市场格局,并确定最有可能保证强劲回报的细分市场
  • 通过了解不断变化的趋势,保持领先地位亚太地区免疫组织化学市场的竞争格局
  • 通过识别最有可能销售前景的细分市场,有效规划亚太地区免疫组织化学市场的并购和合作伙伴交易
  • 帮助从敏锐的洞察力中做出明智的业务决策并对亚太地区免疫组化市场各个细分市场的市场表现进行综合分析
  • 获取亚太地区2021-2028年各个细分市场的市场收入预测
  • ul>

    亚太地区免疫组化市场细分

     亚太地区免疫组织化学市场 - 副产品

    • 设备
      • 载玻片染色系统
      • 组织微阵列系统
      • 组织处理系统
      • 载玻片扫描仪
      • 其他设备
    • 抗体
      • 一抗
      • 二抗
    • 试剂
      • 组织学染色
      • 封闭和固定试剂
      • 显色底物
      • 固定试剂
      • 稳定剂
      • 有机溶剂
      • 蛋白水解酶
      • 稀释剂
    • 试剂盒

    亚太地区免疫组织化学市场 - 按应用划分

    • 诊断
      • 癌症
      • 传染病
      • 自身免疫性疾病
      • 糖尿病
      • 肾病
      • 其他
    • 药物检测

    亚太地区免疫组织化学市场 - 最终用户

    • 医院和诊断实验室
    • 研究机构
    • 其他

    亚太地区免疫组织化学市场 - 按国家/地区

    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 其他亚太地区

    亚太地区免疫组织化学市场 - 公司简介

    • Abcam plc
    • 安捷伦科技公司
    • Bio SB
    • BIO-RAD LABORATORIES INC.
    • Cell Signaling Technology, Inc.
    • 丹纳赫
    • F. HOFFMANN-LA ROCHE LTD.
    • MERCK KGaA
    • PerkinElmer Inc.
    • Thermo FISHER SCIENTIFIC INC.

TABLE OF CONTENTS

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        APAC Immunohistochemistry Market – By Product

1.3.2        APAC Immunohistochemistry Market – By Application

1.3.3        APAC Immunohistochemistry Market – By End User

1.3.4        APAC Immunohistochemistry Market – By Country

2.             Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             APAC Immunohistochemistry Market – Market Landscape

4.1       Overview

4.2       APAC PEST Analysis

4.3       Experts Opinion

5.             APAC Immunohistochemistry Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Escalating Incidences of Chronic and Infectious Diseases

5.1.2        Surging R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2       Key Market Restraints

5.2.1        Complications Related to Immunohistochemistry

5.3       Key Market Opportunities

5.3.1        Burgeoning Opportunities in Emerging Countries

5.4       Future Trends

5.4.1        Growing Acceptance of Automation in Immunohistochemistry

5.5       Impact Analysis

6.             Immunohistochemistry Market – APAC Analysis

6.1       APAC Immunohistochemistry Market Revenue Forecast and Analysis

7.             APAC Immunohistochemistry Market Analysis– By Product

7.1       Overview

7.2       APAC Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3       Antibodies

7.3.1        Overview

7.3.2        Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3        Primary Antibodies

7.3.3.1      Overview

7.3.3.2      Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4        Secondary Antibodies

7.3.4.1      Overview

7.3.4.2      Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4       Equipment Market

7.4.1        Overview

7.4.2        Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3        Slide Staining Systems

7.4.3.1      Overview

7.4.3.2      Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4        Tissue Microarrays

7.4.4.1      Overview

7.4.4.2      Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5        Tissue Processing Systems

7.4.5.1      Overview

7.4.5.2      Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6        Slide Scanners

7.4.6.1      Overview

7.4.6.2      Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7        Other Equipments

7.4.7.1      Overview

7.4.7.2      Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5       Reagents Market

7.5.1        Overview

7.5.2        Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3        Histological Stains

7.5.3.1      Overview

7.5.3.2      Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4        Blocking Sera & Reagents Market

7.5.4.1      Overview

7.5.4.2      Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5        Chromogenic Substrates Market

7.5.5.1      Overview

7.5.5.2      Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6        Stabilizers

7.5.6.1      Overview

7.5.6.2      Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7        Proteolytic Enzymes

7.5.7.1      Overview

7.5.7.2      Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8        Organic Solvents

7.5.8.1      Overview

7.5.8.2      Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9        Fixation Reagents

7.5.9.1      Overview

7.5.9.2      Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10     Diluents

7.5.10.1    Overview

7.5.10.2    Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6       Kits Market

7.6.1        Overview

7.6.2        Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8.             APAC Immunohistochemistry Market Analysis – By Application

8.1       Overview

8.2       APAC Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3       Diagnostics

8.3.1        Overview

8.3.2        Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3        Cancer

8.3.3.1      Overview

8.3.3.2      Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4        Infectious Diseases

8.3.4.1      Overview

8.3.4.2      Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5        Autoimmune Diseases

8.3.5.1      Overview

8.3.5.2      Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6        Diabetes Mellitus

8.3.6.1      Overview

8.3.6.2      Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7        Nephrological Diseases

8.3.7.1      Overview

8.3.7.2      Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8        Others

8.3.8.1      Overview

8.3.8.2      Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4       Drug Testing

8.4.1        Overview

8.4.2        Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9.             APAC Immunohistochemistry Market Analysis– By End User

9.1       Overview

9.2       APAC Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3       Hospital & Diagnostic Laboratories

9.3.1        Overview

9.3.2        Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4       Research Institutes

9.4.1        Overview

9.4.2        Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5       Others

9.5.1        Overview

9.5.2        Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.          APAC Immunohistochemistry Market – Country Analysis

10.1    APAC Immunohistochemistry Market Revenue and Forecasts To 2028

10.1.1     Overview

10.1.2     APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.2.1    Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1.1    Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1.2    Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.1.2.1        Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.1.2.2        Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.1.2.3        Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.1.3    Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.1.3.1        Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.1.4    Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.2    China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2.1    China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2.2    China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.2.2.1        China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.2.2.2        China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.2.2.3        China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.2.3    China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.2.3.1        China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.2.4    China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.3    India Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.3.1    India: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.3.2    India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.3.2.1        India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.3.2.2        India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.3.2.3        India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.3.3    India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.3.3.1        India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.3.4    India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.4    South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.4.1    South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.4.3    South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.4.3.1        South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.4.3.2        South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.4.3.3        South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.4.4    South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.5    Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.5.1    Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.5.2    Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.5.2.1        Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.5.2.2        Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.5.2.3        Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.5.3    Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.5.3.1        Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.5.4    Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.6    Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1    Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2    Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.6.2.1        Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.6.2.2        Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.6.2.3        Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.6.3    Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.6.3.1        Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.6.4    Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

11.          Impact Of COVID-19 Pandemic on APAC Immunohistochemistry Market

11.1    APAC: Impact Assessment of COVID-19 Pandemic

12.          Industry Landscape

12.1    Overview

12.2    Organic Developments

12.2.1     Overview

12.3    Inorganic developments

12.3.1     Overview

13.          Company Profiles

13.1    Cell Signaling Technology, Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    F. HOFFMANN-LA ROCHE LTD.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    MERCK KGaA

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    PerkinElmer Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    THERMO FISHER SCIENTIFIC INC.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Abcam plc

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Agilent Technologies, Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    BIO-RAD LABORATORIES INC.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Danaher

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 Bio SB

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.          Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms

LIST OF TABLES

Table 1.             APAC Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2.             Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3.             Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 4.             Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 5.             Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6.             Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 7.             Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 8.             Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 9.             China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10.          China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 11.          China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 12.          China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13.          China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 14.          China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 15.          China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 16.          India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17.          India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 18.          India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 19.          India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 20.          India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 21.          India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 22.          India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 23.          South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 24.          South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 25.          South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 26.          South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 27.          South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 28.          Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 29.          Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 30.          Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 31.          Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 32.          Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 33.          Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 34.          Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 35.          Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 36.          Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 37.          Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 38.          Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 39.          Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 40.          Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 41.          Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 42.          Organic Developments Done By Companies

Table 43.          Inorganic developments done by Companies

Table 44.          Glossary of Terms

LIST OF FIGURES 

Figure 1.           APAC Immunohistochemistry Market Segmentation

Figure 2.           APAC Immunohistochemistry Market Segmentation, By Country

Figure 3.           APAC Immunohistochemistry Market Overview

Figure 4.           Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5.           India to Show Significant Growth During Forecast Period

Figure 6.           APAC PEST Analysis

Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to APAC Immunohistochemistry Market

Figure 8.           APAC Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9.           APAC Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10.        APAC Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        APAC Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        APAC Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        APAC Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        APAC Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        APAC Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16.        APAC Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        APAC Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        APAC Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        APAC Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        APAC Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        APAC Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        APAC Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23.        APAC Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.        APAC Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        APAC Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26.        APAC Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27.        APAC Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28.        APAC Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29.        APAC Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30.        APAC Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31.        APAC Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32.        APAC Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33.        APAC Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34.        APAC Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35.        APAC Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36.        APAC Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37.        APAC Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38.        APAC Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39.        APAC Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40.        APAC Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41.        APAC Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42.        APAC Immunohistochemistry Market Overview, by Country (2021)

Figure 43.        APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44.        Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45.        China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46.        India: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47.        South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48.        Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 49.        Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Figure 50.        Impact of COVID-19 Pandemic in APAC Country Markets

  1. Abcam plc
  2. Agilent Technologies, Inc.
  3. Bio SB
  4. BIO-RAD LABORATORIES INC.
  5. Cell Signaling Technology, Inc.
  6. Danaher
  7. F. HOFFMANN-LA ROCHE LTD.
  8. MERCK KGaA
  9. PerkinElmer Inc.
  10. THERMO FISHER SCIENTIFIC INC.    
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC immunohistochemistry market.    
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the APAC immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies  
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000